<div id="readability-page-1">Crispr Therapeutics (CRSP) pared a loss amid some takeover speculation. There's speculation that a takeover bid for Crispr (CRSP) could be moving along as the potential buyer has hired an adviser to help with a bid, according to traders, who cited a Betaville &#34;uncooked&#34; alert that was circulating on Monday. People following the matter have heard ta...</div>

CRISPR治疗

<p>Crispr Therapeutics (CRSP) 正在经历收购猜测，有报道称潜在买家已聘请顾问，并可能与律师事务所 Skadden 合作进行出价。Betaville 之前曾提到一家市值在 1000 亿至 2000 亿美元之间的美国生物制药公司对此表示兴趣。交易员们正在密切关注事态发展</p>

在收购猜测中，CRISPR Therapeutics 减少了亏损